Search by Drug Name or NDC

    NDC 55150-0335-01 CARBOPLATIN 450 mg/45mL Details

    CARBOPLATIN 450 mg/45mL

    CARBOPLATIN is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is CARBOPLATIN.

    Product Information

    NDC 55150-0335
    Product ID 55150-335_cfbace29-2dee-41d7-9025-8cc963adbc79
    Associated GPIs 21100015002040
    GCN Sequence Number 038450
    GCN Sequence Number Description carboplatin VIAL 10 MG/ML INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 09217
    HICL Sequence Number 003904
    HICL Sequence Number Description CARBOPLATIN
    Brand/Generic Generic
    Proprietary Name CARBOPLATIN
    Proprietary Name Suffix n/a
    Non-Proprietary Name CARBOPLATIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 450
    Active Ingredient Units mg/45mL
    Substance Name CARBOPLATIN
    Labeler Name Eugia US LLC
    Pharmaceutical Class Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205487
    Listing Certified Through 2024-12-31

    Package

    NDC 55150-0335-01 (55150033501)

    NDC Package Code 55150-335-01
    Billing NDC 55150033501
    Package 1 VIAL, MULTI-DOSE in 1 CARTON (55150-335-01) / 45 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 2016-09-29
    NDC Exclude Flag N
    Pricing Information N/A